Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
Ways for vaccines improvment are described. WHO criteria and domestic requirements for influenza vaccines quality are presented. The multicenter, double-blind, randomized trial in parallel groups of the first Russian quadrivalent vaccine is described in details. Multicenter study for assessment of v...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2018-09-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839576377299304448 |
|---|---|
| author | D. A. Lioznov |
| author_facet | D. A. Lioznov |
| author_sort | D. A. Lioznov |
| collection | DOAJ |
| description | Ways for vaccines improvment are described. WHO criteria and domestic requirements for influenza vaccines quality are presented. The multicenter, double-blind, randomized trial in parallel groups of the first Russian quadrivalent vaccine is described in details. Multicenter study for assessment of vaccine safety, reactogenicity and immunogenicity was performed in 612 volunteers aged 18-60 years in the epidemic season 2016-2017.. In the study conducted , it was demonstrated that the first Russian quadrivalent influenza vaccine has a high tolerability and safety profile and meets the criteria for the immunogenicity of inactivated influenza vaccines. |
| format | Article |
| id | doaj-art-1eebb40c1ab24e4b9e15ff400b96b12f |
| institution | Matheson Library |
| issn | 2073-3046 2619-0494 |
| language | Russian |
| publishDate | 2018-09-01 |
| publisher | Numikom LLC |
| record_format | Article |
| series | Эпидемиология и вакцинопрофилактика |
| spelling | doaj-art-1eebb40c1ab24e4b9e15ff400b96b12f2025-08-04T13:02:01ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942018-09-011748490457Results of Clinical Trials of the First Russian 4-valent Flu VaccineD. A. Lioznov0Research Institute of Influenza, St. PetersburgWays for vaccines improvment are described. WHO criteria and domestic requirements for influenza vaccines quality are presented. The multicenter, double-blind, randomized trial in parallel groups of the first Russian quadrivalent vaccine is described in details. Multicenter study for assessment of vaccine safety, reactogenicity and immunogenicity was performed in 612 volunteers aged 18-60 years in the epidemic season 2016-2017.. In the study conducted , it was demonstrated that the first Russian quadrivalent influenza vaccine has a high tolerability and safety profile and meets the criteria for the immunogenicity of inactivated influenza vaccines.https://www.epidemvac.ru/jour/article/view/563fluvaccinequadrivalent influenza vaccine |
| spellingShingle | D. A. Lioznov Results of Clinical Trials of the First Russian 4-valent Flu Vaccine Эпидемиология и вакцинопрофилактика flu vaccine quadrivalent influenza vaccine |
| title | Results of Clinical Trials of the First Russian 4-valent Flu Vaccine |
| title_full | Results of Clinical Trials of the First Russian 4-valent Flu Vaccine |
| title_fullStr | Results of Clinical Trials of the First Russian 4-valent Flu Vaccine |
| title_full_unstemmed | Results of Clinical Trials of the First Russian 4-valent Flu Vaccine |
| title_short | Results of Clinical Trials of the First Russian 4-valent Flu Vaccine |
| title_sort | results of clinical trials of the first russian 4 valent flu vaccine |
| topic | flu vaccine quadrivalent influenza vaccine |
| url | https://www.epidemvac.ru/jour/article/view/563 |
| work_keys_str_mv | AT dalioznov resultsofclinicaltrialsofthefirstrussian4valentfluvaccine |